An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
To obtain more objective data on response to therapy and to overcome parents', teachers', psychologists', and physicians' concerns about potential overuse, I instituted individual double-blind crossover trials of methylphenidate for children with attention deficit disorder (ADD). Each child is given 0.3 mg/kg/dose twice daily for 2 weeks and placebo for 2 weeks in random order and in double-blind fashion. Parents and teachers record observations of behavior and academic performance. Analysis of 70 trials and follow-up clinical data demonstrated that (1) 51 children showed improvement in one of the 2-week periods and that period corresponded with methylphenidate therapy in 48 (69%); (2) 6 of the 22 who did not respond to methylphenidate experienced worsening of function while taking the drug; (3) history and physical findings were not helpful in predicting methylphenidate response; (4) there were no serious side effects during the trial; and (5) all but three of the responders took methylphenidate for at least 1 year with sustained improvement in behavioral function, academic function, or both. Individual double-blind crossover trials can be used in an office setting to identify objectively which children with ADD respond to treatment with methylphenidate. Because the trial demonstrates to parents, teachers, psychologists, and physicians that methylphenidate is or is not beneficial to a particular child, this clinical tool is associated with a high level of confidence that the drug is being appropriately prescribed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sprague, R. L., & Sleator, E. K. (1977) · Science · doi:10.1126/science.337493 · Cited by 441
Berry, C. A., Shaywitz, S. E., & Shaywitz, B. A. (1985) · PEDIATRICS · doi:10.1542/peds.76.5.801 · Cited by 262
Can the Physician Diagnose Hyperactivity in the Office?
Sleator, E. K., & Ullmann, R. K. (1981) · Pediatrics · doi:10.1542/peds.67.1.13 · Cited by 109
Cited by
Dulcan, M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00007 · Cited by 628
Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003) · Applied Psychophysiology and Biofeedback · doi:10.1023/a:1022353731579 · Cited by 425
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Efron, D., Jarman, F., & Barker, M. (1997) · PEDIATRICS · doi:10.1542/peds.100.6.e6 · Cited by 94
Tirosh, E. (1993) · American Journal of Diseases of Children · doi:10.1001/archpedi.1993.02160360055018 · Cited by 87
Metadata
- Authors
- McBride, M. C.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1988-07
- Volume
- 113
- Issue
- 1
- Pages
- 137-145
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2048036531
- Cited by
- 61
- References
- 3
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. https://app.cochat.ai/papers/10.1016/s0022-3476(88)80548-1
- The paper
- McBride, M. C. (1988). An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(88)80548-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.